\-\ Texto\\:\\ \ \(0\)\
\-\ unremarkable\\.\\ \\ thin\\ elderly\\ woman\\ in\\ nad\\.\ \(0\)\
\-\ underwent\\ chemo\\ and\\ xrt\\ with\\ marked\\ reduction\\ in\\ tumor\\ burden\\.\\ \\ evidence\\ of\\ metastatic\\ disease\\ on\\ 6\\ month\\ follow\\-up\\ ct\\.\ \(0\)\
\-\ squamous\\ cell\\ carcinoma\\ of\\ the\\ proximal\\ esophagus\ \(0\)\
\-\ progressive\\ solid\\ dysphagia\\ and\\ voice\\ hoarseness\\.\ \(1\)\
\-\ although\\ the\\ entire\\ ct\\ chest\\ examination\\ was\\ not\\ provided\\ patient\\ did\\ not\\ have\\ evidence\\ of\\ metastatic\\ disease\\ at\\ the\\ time\\ of\\ diagnosis\\ \\(no\\ parenchymal\\ lesions\\,\\ hilar\\ or\\ mediastinal\\ lymphadenopathy\\.\\ \\ no\\ invasion\\ of\\ the\\ aorta\\)\\.\ \(0\)\
\-\ Keywords\\ by\\ value\\:\\ \ \(0\)\
\-\ chemo\\:\\ 0\\.0772025826119329\ \(0\)\
\-\ burden\\:\\ 0\\.0744813197910279\ \(0\)\
\-\ voice\\:\\ 0\\.07369426465520386\ \(0\)\
\-\ xrt\\:\\ 0\\.07097300183429887\ \(0\)\
\-\ hoarseness\\:\\ 0\\.06981068256839247\ \(0\)\
\-\ elderly\\:\\ 0\\.06135766817131996\ \(0\)\
\-\ nad\\:\\ 0\\.05778025585439974\ \(0\)\
\-\ evidence\\:\\ 0\\.05464494105772873\ \(0\)\
\-\ metastatic\\:\\ 0\\.052466083015026595\ \(0\)\
\-\ hilar\\:\\ 0\\.052362559108749485\ \(0\)\
\-\ entire\\:\\ 0\\.0512243647210395\ \(0\)\
\-\ parenchymal\\:\\ 0\\.0512243647210395\ \(0\)\
\-\ squamous\\:\\ 0\\.050985237021181254\ \(0\)\
\-\ dysphagia\\:\\ 0\\.050750708217182625\ \(0\)\
\-\ invasion\\:\\ 0\\.05018339095334246\ \(0\)\
\-\ reduction\\:\\ 0\\.049122276599810395\ \(0\)\
\-\ esophagus\\:\\ 0\\.04523869451299899\ \(0\)\
\-\ provided\\:\\ 0\\.04494658181760274\ \(0\)\
\-\ aorta\\:\\ 0\\.044731999355524944\ \(0\)\
\-\ lymphadenopathy\\:\\ 0\\.0443138399228587\ \(0\)\
\-\ mediastinal\\:\\ 0\\.04424551973324077\ \(0\)\
\-\ thin\\:\\ 0\\.042831872145212474\ \(0\)\
\-\ solid\\:\\ 0\\.041565203079346094\ \(0\)\
\-\ progressive\\:\\ 0\\.041188281890771984\ \(0\)\
\-\ marked\\:\\ 0\\.04066926220273789\ \(0\)\
\-\ did\\:\\ 0\\.03762705659747468\ \(0\)\
\-\ underwent\\:\\ 0\\.035758488237539264\ \(0\)\
\-\ although\\:\\ 0\\.035194259519226875\ \(0\)\
\-\ unremarkable\\:\\ 0\\.03450080998392757\ \(0\)\
\-\ disease\\:\\ 0\\.034066769297944006\ \(0\)\
\-\ follow\\-up\\:\\ 0\\.03390289013953344\ \(0\)\
\-\ examination\\:\\ 0\\.03239540287164104\ \(0\)\
\-\ proximal\\:\\ 0\\.03128711197203677\ \(0\)\
\-\ month\\:\\ 0\\.03126359196098304\ \(0\)\
\-\ 6\\:\\ 0\\.031123416602132616\ \(0\)\
\-\ not\\:\\ 0\\.030117528579071597\ \(0\)\
\-\ carcinoma\\:\\ 0\\.02953570329287642\ \(0\)\
\-\ time\\:\\ 0\\.029434161307796497\ \(0\)\
\-\ ct\\:\\ 0\\.029153747643708365\ \(0\)\
\-\ cell\\:\\ 0\\.02814927697050593\ \(0\)\
\-\ lesions\\:\\ 0\\.0278970793456579\ \(0\)\
\-\ chest\\:\\ 0\\.02493571951289657\ \(0\)\
\-\ tumor\\:\\ 0\\.024295515873302576\ \(0\)\
\-\ woman\\:\\ 0\\.02407198716449886\ \(0\)\
\-\ diagnosis\\:\\ 0\\.02392950403390756\ \(0\)\
\-\ have\\:\\ 0\\.022566318028842583\ \(0\)\
\-\ no\\:\\ 0\\.02098644270009273\ \(0\)\
\-\ at\\:\\ 0\\.01411906283941016\ \(0\)\
\-\ or\\:\\ 0\\.01221369206053302\ \(0\)\
\-\ was\\:\\ 0\\.012052164905044961\ \(0\)\
\-\ patient\\:\\ 0\\.01044624305995595\ \(0\)\
\-\ in\\:\\ 0\\.010277981222933047\ \(0\)\
\-\ on\\:\\ 0\\.008827939175188147\ \(0\)\
\-\ \\(\\:\\ 0\\.008809289344437324\ \(0\)\
\-\ \\)\\:\\ 0\\.008701679172113477\ \(0\)\
\-\ of\\:\\ 0\\.00710389029256027\ \(0\)\
\-\ the\\:\\ 0\\.006743867546518332\ \(0\)\
\-\ and\\:\\ 0\\.004390463554444352\ \(0\)\
\-\ \\,\\:\\ 0\\.003301342262405944\ \(0\)\
\-\ \\.\\:\\ 0\\.0030304482034319994\ \(0\)\
\-\ with\\:\\ 0\\.0014268801962181675\ \(0\)\
